Bone Conduction Hearing Level in Patients With Eosinophilic Otitis Media Associated With Bronchial Asthma

被引:25
|
作者
Iino, Yukiko [1 ]
Usubuchi, Hajime [1 ]
Kodama, Kozue [1 ]
Takizawa, Katsumi [1 ]
Kanazawa, Takeharu [1 ]
Ohta, Yasushi [1 ]
机构
[1] Jichi Med Univ Saitama, Med Ctr, Dept Otolaryngol, Saitama, Japan
关键词
Bone conduction hearing level; Eosinophilic otitis media; Middle ear mucosa; Pathogen; Sensorineural hearing loss;
D O I
10.1097/MAO.0b013e318185fb0d
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Eosinophilic otitis media (EOM) is characterized by the extensive accumulation of eosinophils in the middle ear mucosa and middle ear effusion and is usually associated with bronchial asthma. EOM patients show gradual deterioration of hearing and sometimes become deaf suddenly. However, there have been no systemic studies of bone conduction hearing level (BCHL) of patients with EOM. Patients: Seventy-one ears of 38 patients with EOM associated with bronchial asthma were included in this study. For controls, 65 cars of age-matched 60 patients with chronic otitis media (COM), who underwent tympanoplasty, were similarly studied. The BCHLs at 250, 500, 1,000, 2,000 and 4,000 Hz of EOM patients were compared with those of COM patients, and the clinical risk factors for the deterioration of BCHL in EOM were analyzed. Results: Two patients became profoundly deaf unilaterally after the onset of EOM. High-tone loss was more frequently found and more severe in EOM patients than in COM patients. The clinical risk factors for high-tone loss were older age, male sex, presence of pathogens, and condition of the middle ear mucosa. Conclusion: High-tone hearing loss and profound hearing loss were frequently associated with EOM, suggesting that inflammatory products of the middle ear invade the inner ear via the round window to cause inner ear damage. To prevent the deterioration of BCHL, the control of eosinophilic inflammation and bacterial infection is mandatory.
引用
收藏
页码:949 / 952
页数:4
相关论文
共 43 条
  • [1] Eosinophilic Inflammation in the Middle Ear Induces Deterioration of Bone-Conduction Hearing Level in Patients With Eosinophilic Otitis Media
    Iino, Yukiko
    Usubuchi, Hajime
    Kodama, Kozue
    Kanazawa, Hiromi
    Takizawa, Katsumi
    Kanazawa, Takeharu
    Ohta, Yasushi
    OTOLOGY & NEUROTOLOGY, 2010, 31 (01) : 100 - 104
  • [2] Dupilumab therapy for patients with refractory eosinophilic otitis media associated with bronchial asthma
    Iino, Yukiko
    Sekine, Yasuhiro
    Yoshida, Saeko
    Kikuchi, Saori
    AURIS NASUS LARYNX, 2021, 48 (03) : 353 - 360
  • [3] Efficacy of Biologics on Refractory Eosinophilic Otitis Media Associated with Bronchial Asthma or Severe Uncontrolled CRSwNP
    De Corso, Eugenio
    Montuori, Claudio
    Settimi, Stefano
    Mele, Dario Antonio
    Cantiani, Alessandro
    Corbo, Marco
    Cantone, Elena
    Paludetti, Gaetano
    Galli, Jacopo
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (04)
  • [4] Eosinophilic Otitis Media Is Associated with Asthma Severity and Smoking History
    Seo, Yukako
    Nonaka, Manabu
    Tagaya, Etsuko
    Tamaoki, Jun
    Yoshihara, Toshio
    ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY, 2015, 77 (01): : 1 - 9
  • [5] Eosinophilic otitis media and comorbid asthma
    Seo, Yukako
    Nonaka, Manabu
    Pawankar, Ruby
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 20 (01) : 9 - 13
  • [6] Differentiation Between Eosinophilic Otitis Media and Otitis Media Associated With Eosinophilic Granulomatosis With Polyangiitis
    Fukuda, Atsushi
    Morita, Shinya
    Nakamaru, Yuji
    Hoshino, Kimiko
    Fujiwara, Keishi
    Homma, Akihiro
    OTOLOGY & NEUROTOLOGY, 2019, 40 (08) : E796 - E802
  • [7] Successful treatment of eosinophilic otitis media associated with severe bronchial asthma with an anti-IL-5 monoclonal antibody, mepolizumab
    Suzaki, Isao
    Kimura, Yurika
    Tanaka, Akihiko
    Hirano, Kojiro
    Ishibashi, Atsushi
    Mizuyoshi, Tomomi
    Ando, Izumi
    Kitajima, Tatsuya
    Watanabe, So
    Hinohira, Yasuyuki
    Kobayashi, Hitome
    AURIS NASUS LARYNX, 2019, 46 (01) : 141 - 146
  • [8] Optimal control of asthma improved eosinophilic otitis media
    Seo, Yukako
    Nonaka, Manabu
    Yamamura, Yukie
    Pawankar, Ruby
    Tagaya, Etsuko
    ASIA PACIFIC ALLERGY, 2018, 8 (01)
  • [9] Improvement of Eosinophilic Otitis Media by Optimized Asthma Treatment
    Tanaka, Yukako
    Nonaka, Manabu
    Yamamura, Yukie
    Tagaya, Etsuko
    Pawankar, Ruby
    Yoshihara, Toshio
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2013, 5 (03) : 175 - 178
  • [10] Rapid and remarkable effectiveness of benralizumab for treating severe bronchial asthma with intractable eosinophilic rhinosinusitis and eosinophilic otitis media: A case report
    Shimizu, Hideyasu
    Kato, Hisayuki
    Yoshioka, Satoshi
    Okazawa, Mitsushi
    RESPIRATORY MEDICINE CASE REPORTS, 2021, 32